Tacrolimus (topical)
Indication
Topical treatment for atopic dermatitis (NICE TA82)
NICE TA82 - Tacrolimus and pimecrolimus for atopic eczema
MHRA Drug Safety Update - Tacrolimus ointment (Protopic): possible risk of malignancies including lymphomas and skin cancers
Amber level 0
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Skin
Background
LSCMMG is adopting the local decisions made prior to April 2013
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist
Supporting documents: